BioCardia Lands $35,873,625 New Financing

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    125 Shoreway Road San Carlos, CA 94070 USA
  • Company Description
    BioCardia’s Helix Biotherapeutic Delivery business remains committed to being the platform of choice for delivery of therapeutic agents to themyocardium.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 31 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor

Trending on Xconomy